Works matching DE "AFATINIB"

Results: 185

Design, Synthesis and Biological Evaluation of Several Novel 4-aminoquinazoline Derivatives as Potent Anti-Tumor Agents.

Published in:

Journal of the Chemical Society of Pakistan, 2023, v. 45, n. 6, p. 474, doi. 10.52568/001391/jcsp/45.06.2023

By:

Liang

Publication type:

Article

"ACHILLES" Heel No More? Afatinib at 40 Mg Once Daily is Superior to Platinum-Based Chemotherapy in EGFR Uncommon (G719X, S768I, and L861Q) Mutations (ACHILLES/TORG1834).

Published in:

Lung Cancer: Targets & Therapy, 2024, v. 15, p. 69, doi. 10.2147/LCTT.S461758

By:

Luo, Faustine X;
Ou, Sai-Hong Ignatius

Publication type:

Article

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece

Published in:

Lung Cancer: Targets & Therapy, 2021, v. 12, p. 93, doi. 10.2147/LCTT.S318007

By:

Mountzios, Giannis;
Lampaki, Sofia;
Koliou, Georgia-Angeliki;
Vozikis, Athanassios;
Kontogiorgos, Ioannis;
Papantoniou, Panagiotis;
Koufaki, Margarita-Ioanna;
Res, Eleni;
Boutis, Anastasios;
Christopoulou, Athina;
Pastelli, Nicoleta;
Grivas, Anastasios;
Aravantinos, Gerasimos;
Lalla, Efthalia;
Oikonomopoulos, Georgios;
Koumarianou, Anna;
Spyratos, Dionisios;
Snr, Dimitrios Bafaloukos;
Rigakos, Georgios;
Papakotoulas, Pavlos

Publication type:

Article

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non--Small Cell Lung Cancer: Updated Analysis of the RESET Study.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1152, doi. 10.4143/crt.2023.493

By:

Taeyun Kim;
Tae Won Jang;
Chang Min Choi;
Mi-Hyun Kim;
Sung Yong Lee;
Yoon Soo Chang;
Kye Young Lee;
Seung Joon Kim;
Sei Hoon Yang;
Jeong Seon Ryu;
Jeong Eun Lee;
Shin Yup Lee;
Chan Kwon Park;
Sang Hoon Lee;
Seung Hun Jang;
Seong Hoon Yoon;
Hyung-Joo Oh

Publication type:

Article

The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 2, p. 479, doi. 10.4143/crt.2022.1344

By:

Hyun Ae Jung;
Sehhoon Park;
Se-Hoon Lee;
Jin Seok Ahn;
Myung-Ju Ahn;
Jong-Mu Sun

Publication type:

Article

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.

Published in:

Cancer Research & Treatment, 2019, v. 51, n. 2, p. 502, doi. 10.4143/crt.2018.117

By:

Youjin Kim;
Se-Hoon Lee;
Jin Seok Ahn;
Myung-Ju Ahn;
Keunchil Park;
Jong-Mu Sun

Publication type:

Article

Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer.

Published in:

Cancer Research & Treatment, 2017, v. 49, n. 4, p. 1001, doi. 10.4143/crt.2016.546

By:

Youngjoo Lee;
Ki Hyeong Lee;
Geon Kook Lee;
Soo-Hyun Lee;
Kun Young Lim;
Jungnam Joo;
Yun Jung Go;
Jin Soo Lee;
Ji-Youn Han

Publication type:

Article

Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40349-z

By:

Bian, Dongliang;
Sun, Liangdong;
Hu, Junjie;
Duan, Liang;
Xia, Haoran;
Zhu, Xinsheng;
Sun, Fenghuan;
Zhang, Lele;
Yu, Huansha;
Xiong, Yicheng;
Huang, Zhida;
Zhao, Deping;
Song, Nan;
Yang, Jie;
Bao, Xiao;
Wu, Wei;
Huang, Jie;
He, Wenxin;
Zhu, Yuming;
Jiang, Gening

Publication type:

Article

The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.

Published in:

Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 601, doi. 10.1007/s13402-022-00686-5

By:

Shu, Wenying;
Zhu, Xue;
Wang, Ke;
Cherepanoff, Svetlana;
Conway, R. Max;
Madigan, Michele C.;
Zhu, Hong;
Zhu, Ling;
Murray, Michael;
Zhou, Fanfan

Publication type:

Article

Cancer Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK DEFINE Database.

Published in:

Cancers, 2025, v. 17, n. 2, p. 311, doi. 10.3390/cancers17020311

By:

Chan, Stefanie Ho Yi;
Fitzpatrick, Raymond W.;
Layton, Deborah;
Webley, Sherael;
Salek, Sam

Publication type:

Article

Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art.

Published in:

Cancers, 2024, v. 16, n. 7, p. 1331, doi. 10.3390/cancers16071331

By:

Fabrizio, Federico Pio;
Attili, Ilaria;
de Marinis, Filippo

Publication type:

Article

Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study).

Published in:

Cancers, 2023, v. 15, n. 23, p. 5568, doi. 10.3390/cancers15235568

By:

Ji, Wonjun;
Oh, In-Jae;
Park, Cheol-Kyu;
Lee, Sung Yong;
Choi, Juwhan;
Lee, Jae Cheol;
Kim, Jiwon;
Lee, Seung Hyeun

Publication type:

Article

Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer.

Published in:

Cancers, 2023, v. 15, n. 10, p. 2681, doi. 10.3390/cancers15102681

By:

Noortman, Wyanne A.;
Aide, Nicolas;
Vriens, Dennis;
Arkes, Lisa S.;
Slump, Cornelis H.;
Boellaard, Ronald;
Goeman, Jelle J.;
Deroose, Christophe M.;
Machiels, Jean-Pascal;
Licitra, Lisa F.;
Lhommel, Renaud;
Alessi, Alessandra;
Woff, Erwin;
Goffin, Karolien;
Le Tourneau, Christophe;
Gal, Jocelyn;
Temam, Stéphane;
Delord, Jean-Pierre;
van Velden, Floris H. P.;
de Geus-Oei, Lioe-Fee

Publication type:

Article

Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR -Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib.

Published in:

Cancers, 2023, v. 15, n. 7, p. 2019, doi. 10.3390/cancers15072019

By:

Tsai, Ming-Ju;
Hung, Jen-Yu;
Ma, Juei-Yang;
Tsai, Yu-Chen;
Wu, Kuan-Li;
Lee, Mei-Hsuan;
Kuo, Chia-Yu;
Chuang, Cheng-Hao;
Lee, Tai-Huang;
Lee, Yen-Lung;
Huang, Chun-Ming;
Shen, Mei-Chiou;
Yang, Chih-Jen;
Chong, Inn-Wen

Publication type:

Article

Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs.

Published in:

Cancers, 2023, v. 15, n. 5, p. 1582, doi. 10.3390/cancers15051582

By:

Boyd, David C.;
Zboril, Emily K.;
Olex, Amy L.;
Leftwich, Tess J.;
Hairr, Nicole S.;
Byers, Holly A.;
Valentine, Aaron D.;
Altman, Julia E.;
Alzubi, Mohammad A.;
Grible, Jacqueline M.;
Turner, Scott A.;
Ferreira-Gonzalez, Andrea;
Dozmorov, Mikhail G.;
Harrell, J. Chuck

Publication type:

Article

Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes.

Published in:

Cancers, 2023, v. 15, n. 1, p. 187, doi. 10.3390/cancers15010187

By:

Kuo, Chia-Yu;
Tsai, Ming-Ju;
Hung, Jen-Yu;
Wu, Kuan-Li;
Tsai, Ying-Ming;
Tsai, Yu-Chen;
Chuang, Cheng-Hao;
Lee, Tai-Huang;
Chen, Huang-Chi;
Yang, Chih-Jen;
Chong, Inn-Wen

Publication type:

Article

Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparative Cohort Study in China (AFANDA Study).

Published in:

Cancers, 2022, v. 14, n. 21, p. 5307, doi. 10.3390/cancers14215307

By:

Li, Hong-Shuai;
Wang, Shou-Zheng;
Xu, Hai-Yan;
Yan, Xiang;
Zhang, Jin-Yao;
Lei, Si-Yu;
Li, Teng;
Hao, Xue-Zhi;
Zhang, Tao;
Yang, Guang-Jian;
Zhou, Li-Qiang;
Liu, Peng;
Wang, Yu-Ying;
Hu, Xing-Sheng;
Xing, Pu-Yuan;
Wang, Yan

Publication type:

Article

Molecularly Targeted Photothermal Ablation of Epidermal Growth Factor Receptor-Expressing Cancer Cells with a Polypyrrole–Iron Oxide–Afatinib Nanocomposite.

Published in:

Cancers, 2022, v. 14, n. 20, p. 5043, doi. 10.3390/cancers14205043

By:

Rethi, Lekshmi;
Mutalik, Chinmaya;
Rethi, Lekha;
Chiang, Wei-Hung;
Lee, Hsin-Lun;
Pan, Wen-Yu;
Yang, Tze-Sen;
Chiou, Jeng-Fong;
Chen, Yin-Ju;
Chuang, Er-Yuan;
Lu, Long-Sheng

Publication type:

Article

Comparison of Second-Line Treatments for Patients with Platinum-Resistant Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Bayesian Network Meta-Analysis.

Published in:

Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184472

By:

He, Yan;
Zeng, Junsong;
Wei, Zhigong;
Huang, Yan;
Yang, Lianlian;
Hu, Xiaolin;
Su, Yonglin;
Peng, Xingchen

Publication type:

Article

Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody–Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-Analysis.

Published in:

Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143372

By:

Wang, Yan;
Xu, Hangcheng;
Han, Yiqun;
Wu, Yun;
Wang, Jiayu

Publication type:

Article

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI.

Published in:

Cancers, 2022, v. 14, n. 4, p. 977, doi. 10.3390/cancers14040977

By:

Chang, John Wen-Cheng;
Huang, Chen-Yang;
Fang, Yueh-Fu;
Chang, Ching-Fu;
Yang, Cheng-Ta;
Kuo, Chih-Hsi Scott;
Hsu, Ping-Chih;
Wu, Chiao-En

Publication type:

Article

First-line Afatinib in Epidermal Growth Factor Receptor-mutant Metastatic Non-small Cell Lung Cancer: a Clinical Retrospective Study.

Published in:

Hong Kong Journal of Radiology, 2022, v. 25, n. 3, p. 184, doi. 10.12809/hkjr2217459

By:

Chow, D. Y. L.;
So, T. H.;
Leung, D. K. C.;
Tse, R. P. Y.;
Lau, K. S.

Publication type:

Article

Investigation on the interaction behavior of afatinib, dasatinib, and imatinib docked to the BCR-ABL protein.

Published in:

Journal of Molecular Modeling, 2021, v. 27, n. 10, p. 1, doi. 10.1007/s00894-021-04925-8

By:

Rocha, Kelvyn M. L.;
Nascimento, Érica C. M.;
Martins, João B. L.

Publication type:

Article

AZD8055 enhances in vivo efficacy of afatinib in chordomas.

Published in:

Journal of Pathology, 2021, v. 255, n. 1, p. 72, doi. 10.1002/path.5739

By:

Zhao, Tianna;
Siu, I‐Mei;
Williamson, Tara;
Zhang, Haoyu;
Ji, Chenchen;
Burger, Peter C;
Connis, Nick;
Ruzevick, Jacob;
Xia, Menghang;
Cottone, Lucia;
Flanagan, Adrienne M;
Hann, Christine L;
Gallia, Gary L

Publication type:

Article

Durable response to afatinib in advanced lung adenocarcinoma harboring a novel NPTN-NRG1 fusion: a case report.

Published in:

2023

By:

Nie, Xin;
Zhang, Ping;
Bie, Zhixin;
Song, Chenhui;
Zhang, Min;
Ma, Di;
Cui, Di;
Cheng, Gang;
Li, Hui;
Lei, Yan;
Su, Xiaoxing;
Wu, Wendy;
Li, Lin

Publication type:

Case Study

Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients.

Published in:

2021

By:

Chen, You-Yi;
Chang, Shih-Chieh;
Chang, Cheng-Yu;
Chang, Chun-Fu;
Lai, Yi-Chun;
Wei, Yu-Feng;
Chen, Chung-Yu

Publication type:

journal article

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.

Published in:

2021

By:

Wu, Chiao-En;
Chang, Ching-Fu;
Huang, Chen-Yang;
Yang, Cheng-Ta;
Kuo, Chih-Hsi Scott;
Hsu, Ping-Chih;
Chang, John Wen-Cheng

Publication type:

journal article

Indian experience of Afatinib for EGFR mutation-positive advanced lung adenocarcinoma a real-world retrospective study.

Published in:

Indian Journal of Cancer, 2024, v. 61, n. 4, p. 671, doi. 10.4103/ijc.IJC_893_20

By:

Batra, Ullas;
Sharma, Mansi;
Jain, Parveen;
Narayan, Satya;
Jain, Arpit;
Soni, Satyajeet;
Nathany, Shrinidhi

Publication type:

Article

Weekly Afatinib in the Treatment of Advanced Non-small Cell Lung Cancer with EGFR-G719C Mutation Followed by Lobectomy: A Case Report.

Published in:

International Journal of Cancer Management, 2024, v. 17, n. 1, p. 1, doi. 10.5812/ijcm-143390

By:

Dung Xuan Ho;
Long Thien Phan;
Hung Manh Vuong;
Kha Nguyen Dang

Publication type:

Article

Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling.

Published in:

Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1198118

By:

Chao Yu;
Xinyi Zhang;
Min Wang;
Gaoxin Xu;
Siqi Zhao;
Yongheng Feng;
Chao Pan;
Weijun Yang;
Jin Zhou;
Longcheng Shang;
Yong Ma

Publication type:

Article

CNS efficacy of afatinib as firstline treatment in advanced nonsmall cell lung cancer patients with EGFR mutations.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1094195

By:

Liping Kang;
Jianliang Mai;
Weiting Liang;
Qihua Zou;
Caiwen Huang;
Yongbin Lin;
Ying Liang

Publication type:

Article

NSCLC patients with rare EGFR Ex19del/G724S mutation showed good response to afatinib combined with chemotherapy treatment: A two-case report.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054593

By:

Huilin Wang;
Qitao Yu;
Lina Shi;
Qinhan Hou;
Liang Dan;
Chuqiao Liang;
Xiaoyu Hong;
Yun Zhao;
Ruiling Ning

Publication type:

Article

Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.999606

By:

Wei Dong;
Congjie Wang;
Chunsheng Wang;
Kewei Zhao;
Zhao Ma;
Shanliang Hu

Publication type:

Article

"From molecular to clinic": The pivotal role of CDC42 in pathophysiology of human papilloma virus related cancers and a correlated sensitivity of afatinib.

Published in:

Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1118458

By:

Wei, Erdong;
Jiahua Li;
Anand, Philipp;
French, Lars E.;
Wattad, Adam;
Clanner-Engelshofen, Benjamin;
Reinholz, Markus

Publication type:

Article

Research Progress and New Perspectives of Anticancer Effects of Emodin.

Published in:

American Journal of Chinese Medicine, 2023, v. 51, n. 7, p. 1751, doi. 10.1142/S0192415X23500787

By:

Liu, Wu;
Qaed, Eskandar;
Zhu, Yuelin;
Tian, Wenzhang;
Wang, Yizhen;
Kang, Le;
Ma, Xiaodong;
Tang, Zeyao

Publication type:

Article

Recurrent Transient Asymptomatic Pulmonary Opacity with Long-Term Afatinib: A Case Report.

Published in:

Case Reports in Oncology, 2023, v. 16, n. 1, p. 173, doi. 10.1159/000529894

By:

Watanabe, Keisuke;
Kobayashi, Nobuaki;
Kaneko, Takeshi

Publication type:

Article

Successful Treatment of Afatinib-Refractory Non-Small Cell Lung Cancer with Uncommon Complex EGFR Mutations Using Pembrolizumab: A Case Report.

Published in:

Case Reports in Oncology, 2019, v. 12, n. 2, p. 564, doi. 10.1159/000501848

By:

Taniguchi, Yuri;
Yamamoto, Momoko;
Ikushima, Hiroaki;
Ohara, Sayaka;
Takeshima, Hideyuki;
Sakatani, Toshio;
Usui, Kazuhiro

Publication type:

Article

Rapid Response to High-Dose, Pulsatile Erlotinib in Afatinib-Refractory Leptomeningeal Carcinomatosis from Adenocarcinoma of the Lung: A Case Report.

Published in:

Case Reports in Oncology, 2016, v. 9, n. 3, p. 537, doi. 10.1159/000449405

By:

Fan, Frank S.

Publication type:

Article

Afatinib as First-Line Treatment in Elderly Patients with EGFR-Mutant Non-Small Cell Lung Cancer: Real-World Data Analysis.

Published in:

International Journal of Gerontology, 2022, v. 16, n. 3, p. 266, doi. 10.6890/IJGE.202207_16(3).0019

By:

Yen-Ting Chen;
Chia-Te Yen;
Wen-JuiWu;
Sheng-Hsiung Yang

Publication type:

Article

Retracted: Effects of Afatinib on Development of Non-Small-Cell Lung Cancer by Regulating Activity of Wnt/β-Catenin Signaling Pathway.

Published in:

2022

By:

Methods in Medicine, Computational and Mathematical

Publication type:

Correction Notice

Effects of Afatinib on Development of Non-Small-Cell Lung Cancer by Regulating Activity of Wnt/β-Catenin Signaling Pathway.

Published in:

Computational & Mathematical Methods in Medicine, 2022, p. 1, doi. 10.1155/2022/5213016

By:

Wu, Yue;
Zhang, Jiajing;
Yun, Changping;
Dong, Chenchen;
Tian, Ye

Publication type:

Article

Effects of Afatinib on Development of Non-Small-Cell Lung Cancer by Regulating Activity of Wnt/β-Catenin Signaling Pathway.

Published in:

Computational & Mathematical Methods in Medicine, 2022, p. 1, doi. 10.1155/2022/5213016

By:

Wu, Yue;
Zhang, Jiajing;
Yun, Changping;
Dong, Chenchen;
Tian, Ye

Publication type:

Article

Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature.

Published in:

World Journal of Surgical Oncology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12957-021-02444-7

By:

Xu, Huanhuan;
Liang, Qi;
Xu, Xian;
Tan, Shanyue;
Wang, Sumeng;
Liu, Yiqian;
Liu, Lingxiang

Publication type:

Article

Repurposing a Combination of Palbociclib and Afatinib Halts Chordoma Growth in a Mouse Model.

Published in:

GEN Biotechnology, 2025, v. 4, n. 2, p. 91, doi. 10.1089/genbio.2024.0048

By:

Raman, Renuka;
Levy, Joan;
Freed, Daniel M.;
Ekins, Sean

Publication type:

Article

Potential use of lapatinib in the treatment of head and neck squamous cell carcinoma (Review).

Published in:

World Academy of Sciences Journal, 2022, v. 4, n. 5, p. 1, doi. 10.3892/wasj.2022.170

By:

HEALTHYNI, CHRISTINA SRI;
SUBROTO, TOTO;
MEGANTARA, SANDRA;
JIRANUSORNKUL, SUPAT;
LEVITA, JUTTI

Publication type:

Article

Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan.

Published in:

Current Oncology, 2025, v. 32, n. 1, p. 36, doi. 10.3390/curroncol32010036

By:

Kuo, Jerry Shu-Hung;
Chang, Cheng-Yu;
Chang, Shih-Chieh;
Wei, Yu-Feng;
Chen, Chung-Yu

Publication type:

Article

Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review.

Published in:

Current Oncology, 2023, v. 30, n. 6, p. 5337, doi. 10.3390/curroncol30060405

By:

Jiang, Yingying;
Fang, Xiaoxu;
Xiang, Yan;
Fang, Tingwen;
Liu, Jingwen;
Lu, Kaihua

Publication type:

Article

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence.

Published in:

Current Oncology, 2022, v. 29, n. 1, p. 255, doi. 10.3390/curroncol29010024

By:

Attili, Ilaria;
Passaro, Antonio;
Pisapia, Pasquale;
Malapelle, Umberto;
de Marinis, Filippo

Publication type:

Article

Afatinib in advanced pretreated non-small-cell lung cancer--a Canadian experience.

Published in:

Current Oncology, 2018, v. 25, n. 5, p. e385, doi. 10.3747/co.25.3914

By:

Ezeife, D. A.;
Melosky, B.;
Tudor, R.;
Lin, S.;
Lau, A.;
Panzarella, T.;
Leighl, N. B.

Publication type:

Article

Irreversible tyrosine kinase inhibition of epidermal growth factor receptor with afatinib in EGFR activating mutation-positive advanced non-small-cell lung cancer.

Published in:

Current Oncology, 2018, v. 25, p. S9, doi. 10.3747/co.25.3732

By:

Abdallah, S. Morin-Ben;
Hirsh, V.

Publication type:

Article